New combo treatment aims to quiet suicidal thoughts fast
NCT ID NCT07396220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a brief therapy to esketamine nasal spray works better than the spray alone for reducing suicidal thoughts in people with hard-to-treat depression. About 56 adults aged 18 to 70 with ongoing suicidal thoughts will take part. The goal is to see if the combined approach leads to quicker relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC San Diego Health - 4S Ranch
San Diego, California, 92127, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can peer mentors help gay men with HIV stay in care?
- Hope in action: peer support may curb suicide risk in youth facing psychosis
- A phone call after the ER: testing a suicide prevention lifeline
- Can money worries trigger depression in students? a study digs deep
- Special forces veterans test Psychedelic-Device combo for PTSD and brain injury
- Self-Defense as healing: could a culturally grounded program ease trauma in native women?